Poseida Therapeutics (PSTX) Q3 2024 Earnings

5AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.42
-0.36
-0.31
-0.25

Details

Expected EPS
-0.406725
Actual EPS
-0.32
Surprise EPS
0.09
Surprise Percent
+21.32%

Description

Poseida Therapeutics (PSTX) has reported earnings of -0.32 per share for Q3 2024.

0 Comments

Share your thoughts